Nicotine patch safe during pregnancy
This article was originally published in The Tan Sheet
Executive Summary
Long-term nicotine replacement therapy advocated for pregnant women otherwise unable to stop smoking by Paul Ogburn, MD, State University of New York at Stony Brook, et al. Researchers found 22 mg/24 hrs of transdermal nicotine therapy administered for eight weeks did not affect gestational age, birth weight or "fetal well-being" in cohort of 21 pregnant smokers. Study was presented at Society for Maternal-Fetal Medicine's annual meeting in New Orleans Jan. 17 and published in December American Journal of Obstetrics & Gynecology. A California judge ruled last March against requiring that nonprescription NRT products carry labeling stating they "can harm your baby" (1"The Tan Sheet" March 26, 2001, p. 21)...
You may also be interested in...
Smoking Cessation Patch, Gum Prop 65 Warning Federally Preempted - Court
Requiring a special California Proposition 65 pregnancy warning on OTC nicotine-containing smoking cessation patches and gums would conflict with FDA requirements, a San Francisco state court judge has ruled.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.